Guidelines for the administration of blood products.
作者信息
Warwick R, Modi N
机构信息
North London Blood Transfusion Centre.
出版信息
Arch Dis Child. 1995 May;72(5):379-81. doi: 10.1136/adc.72.5.379.
Abstract
摘要
相似文献
1
Guidelines for the administration of blood products.
Arch Dis Child. 1995 May;72(5):379-81. doi: 10.1136/adc.72.5.379.
2
Irradiation of blood products for neonatal exchange transfusion.
Vox Sang. 2009 Nov;97(4):358; author reply 359. doi: 10.1111/j.1423-0410.2009.01229.x.
3
Fulminant transfusion-associated graft-versus-host disease in a premature infant.
J Am Acad Dermatol. 1989 May;20(5 Pt 2):945-50. doi: 10.1016/s0190-9622(89)70116-x.
4
Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis.
N Engl J Med. 1969 Sep 25;281(13):697-701. doi: 10.1056/NEJM196909252811303.
5
[Progress in the field of hematology in the last 100 years: Clinical guidelines for irradiation of blood to prevent graft-versus-host disease following blood transfusion].
Nihon Naika Gakkai Zasshi. 2002 Jul 10;91(7):2161-8.
6
Guidelines for administration of blood products: transfusion of infants and neonates. British Committee for Standards in Haematology Blood Transfusion Task Force.
Transfus Med. 1994 Mar;4(1):63-9. doi: 10.1111/j.1365-3148.1994.tb00245.x.
7
Innocence without virtue--graft-versus-host disease in man.
N Engl J Med. 1969 Sep 25;281(13):732-3. doi: 10.1056/NEJM196909252811311.
8
ABC of transfusion. Fetal and neonatal transfusion.
BMJ. 1990 Mar 31;300(6728):862-6. doi: 10.1136/bmj.300.6728.862.
9
Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012.
Transfus Med. 2013 Aug;23(4):217-8. doi: 10.1111/tme.12060.
10
Transfusion-associated graft-versus-host disease.
Br J Haematol. 2002 May;117(2):275-87. doi: 10.1046/j.1365-2141.2002.03450.x.
本文引用的文献
1
The development of anti-HLA antibodies in multiply transfused preterm infants.
Arch Dis Child. 1993 Jan;68(1 Spec No):49-51. doi: 10.1136/adc.68.1_spec_no.49.
2
HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
Transfus Med Rev. 1993 Jan;7(1):37-41. doi: 10.1016/s0887-7963(93)70031-0.
3
The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
N Engl J Med. 1994 Apr 28;330(17):1173-8. doi: 10.1056/NEJM199404283301701.
4
Review of neonatal red cell transfusion practices.
Blood Rev. 1994 Sep;8(3):148-53. doi: 10.1016/0268-960x(94)90075-s.
5
The in vitro effects of stem cell factor, interleukin 3 and granulocyte-macrophage colony stimulating factor on haemopoietic progenitor cells from premature infants.
Br J Haematol. 1994 Mar;86(3):468-74. doi: 10.1111/j.1365-2141.1994.tb04775.x.
6
Thymic involution mimicking thymic dysplasia: a consequence of transfusion-induced graft versus host disease in a premature infant.
Arch Pathol Lab Med. 1980 Mar;104(3):141-4.
7
Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome.
N Engl J Med. 1983 Mar 31;308(13):743-8. doi: 10.1056/NEJM198303313081303.
8
Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation.
Pediatrics. 1982 Jul;70(1):43-7.
9
Aplastic anemia and alymphocytosis in an infant with hypogammaglobulinemia: graft-versus-host reaction?
J Pediatr. 1966 May;68(5):713-22. doi: 10.1016/s0022-3476(66)80443-2.
10
Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis.
N Engl J Med. 1969 Sep 25;281(13):697-701. doi: 10.1056/NEJM196909252811303.
Zotero 插件